You are here

  • Home
  • Archive
  • Volume 29, Issue 4
  • ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Article info

Article menu

Download PDFPDF

Original Article
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
Free

Authors

  1. Correspondence to N Colombo, ESMO Guidelines Committee, ESMO Head Office, Lugano 6900, Switzerland; clinicalguidelines{at}esmo.org; D Querleu, ESGO Guidelines Committee, ESGO Office, Prague 110 00, Czech Republic; esgo-guidelines{at}esgomail.org
View Full Text

Citation

Colombo N, Sessa C, Bois AD on behalf of the ESMO–ESGO Ovarian Cancer Consensus Conference Working Group, et al
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
International Journal of Gynecologic Cancer 2019;29:728-760.

Publication history

  • Received January 25, 2019
  • Accepted February 25, 2019
  • First published May 2, 2019.
Online issue publication 
February 03, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Authors 2019. No commercial re-use. See rights and permissions. Published by BMJ.